Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIa, Placebo Controlled, Multicenter Pilot Study to Evaluate the Safety and Efficacy of BIO-11006 Inhalation Solution in Patients With Acute Respiratory Distress Syndrome

NCT03202394 is registered in ClinicalTrials.gov with BioMarck Pharmaceuticals, Ltd. as lead sponsor.

NCT NCT03202394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03202394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIa, Placebo Controlled, Multicenter Pilot Study to Evaluate the Safety and Efficacy of BIO-11006 Inhalation Solution in Patients With Acute Respiratory Distress Syndrome
Lead sponsor
BioMarck Pharmaceuticals, Ltd.
Phase
Phase 2
Overall status
Completed
Start date
August 5, 2017
Completion date
June 15, 2020
Enrollment
38 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory distress syndrome, adult